ABRACL: A Potential Drug Target Or Biomarker (G58527)

Target Name: ABRACL

NCBI ID: G58527

ABRACL

ABRACL: A Potential Drug Target Or Biomarker

ABRACL (short for AB rat brain cortical protein) is a protein that is expressed in the rat brain and has been shown to play a role in various cognitive functions, including memory and learning. It is also expressed in other animals, including humans, and is thought to be a potential drug target or biomarker.

The research on ABRACL began in the 1990s, when scientists identified it as a protein that was expressed in the brain and was involved in the formation of new memories. Since then, studies have continued to explore its role in various cognitive functions, including memory and learning.

One of the key findings of these studies is that ABRACL is involved in the formation of new memories. Studies have shown that ABRACL is expressed in the brain and is involved in the formation of new memories, including long-term memories. This suggests that ABRACL may be a key factor in the formation of new memories and may be a potential drug target or biomarker.

Another finding of interest is that ABRACL is involved in the regulation of cell death in the brain. Studies have shown that ABRACL is involved in the regulation of cell death in the brain and that its levels are affected by factors such as stress and neurodegenerative diseases. This suggests that ABRACL may be a potential drug target or biomarker for these conditions.

In addition to its role in memory and cell death, ABRACL is also involved in other cognitive functions, including attention and motor function. Studies have shown that ABRACL is involved in these functions and that its levels are affected by factors such as attention deficit hyperactivity disorder (ADHD) and neurodegenerative diseases. This suggests that ABRACL may be a potential drug target or biomarker for these conditions as well.

Overall, the research on ABRACL is still in its early stages, but it is clear that it is a protein that is involved in various cognitive functions and may be a potential drug target or biomarker. Further research is needed to fully understand its role in the brain and to explore its potential as a drug target or biomarker.

Protein Name: ABRA C-terminal Like

The "ABRACL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ABRACL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets